Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs Sunitinib in advanced non-clear cell renal cell carcinoma (ESPN)
NCT01185366Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2010
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in non-clear cell renal cell carcinoma (nccRCC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2010; status: terminated.
02
Drugs
everolimus
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01185366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185366.